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GM2-Gangliosidosis (Sandhoff and Tay Sachs disease): Diagnosis and 
Neuroimaging Findings (An Iranian Pediatric Case Series)
Abstract
Objective
GM2-Gangliosidosis disease is a rare autosomal recessive genetic disorder that 
includes two disorders (Tay–Sachs and Sandhoff disease).These disorders cause 
a progressive deterioration of nerve cells and inherited deficiency in creating 
hexosaminidases A, B, and AB.
Materials & Methods
Patients who were diagnosed withGM2-Gangliosidosis in the Neurology 
Department of Mofid Children’s Hospital in Tehran, Iran from October2009to 
February 2014were included in our study. The disorder was confirmed by 
neurometabolic and enzyme level detection of hexosaminidases A, B, and AB 
in reference to Wagnester Laboratory in Germany. We assessed age, gender, 
past medical history, developmental status, clinical manifestations, and neuro-
imaging findings of 9 patients with Sandhoff disease and 9 with Tay Sachs 
disease.
Results
83% of our patients were the offspring of consanguineous marriages. All of 
them had a developmental disorder as a chief complaint.
38%of patients had a history of developmental delay or regression and 22% had 
seizures. The patients with Sandhoff and Tay Sachs disease were followed for 
approximately 5 years and the follow-up showed all patients were bedridden 
or had expired due to refractory seizures, pneumonia aspiration, or swallowing 
disorders.
Neuro-imaging findings included bilateral thalamic involvement, brain atrophy, 
and hypo myelination in near half of our patients (48%).
Conclusion
According to the results of this study, we suggest that cherry-red spots, hyperacusis, 
refractory seizures, and relative parents in children with developmental delay 
and/or regression should be considered for assessment of GM2-Gangliosidosis 
disease.
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Introduction
Sandhoff disease is a rare autosomal recessive metabolic disorder that has three 
clinical subtypes (infantile, juvenile, and adult forms)(1,2).The infantile form 
presents with progressive neurologic impairment, hyperacusis, hypotonia, and 
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for participation in this study.
 
Results
In our study 18 patients with GM2-Gangliosidosis (9 
patients with Sandhoff and 9 with Tay Sachs disease) 
were included. There were 10 males and 8 females with 
a mean age at time of presentation of15 months and an 
average age of18 months. Hospitalization history for 2 
patients from maternal preeclampsia and for 4 patients 
from pneumonia (1 patient) and icter (3 patients).
The first and chief complaint in 100% of the patients were 
neurological disorders, such as developmental delays (6 
patients), developmental regression (5 patients), or both 
(7 patients); and 4 patients complained of simultaneous 
seizures. 
During developmental assessment, 66% of patients 
showed developmental regression. The average age for 
developmental regression was 15 months and the mean 
age was 12 months(3 months before admission and 
detection time).Four patients had a history of recurrent 
hospitalization because of respiratory and urinary tract 
infections. Eight patients had central hypo tonicity 
(decreased tonicity and increased DTR) and5 patients 
had spasticity.55% of patients had visual disorders and 
fix-follow did not exist during physical examinations. 
Nine patients had a history of seizure with the most 
common form of seizure were tonic-myoclonic seizures. 
Seven patients had hyperacusis. 55% of patients had a 
dysmorphic face with protruding forehead, depressed 
nasal bridge, and hypertelorism. Five patients had blond 
hair (Fig. 1). One patient had hepatomegaly and another 
had hepato splenomegaly. Weight in 6 patients was 
below the 3 percentile and height in 10% of patients was 
below the 5 percentile. Three patients had microcephaly, 
seven patients showed macrocephaly, and the remainder 
had normal head circumferences.83% of patients were 
the offspring from consanguineous marriages. Four 
patients had a family history of seizures and mental 
retardation. No abnormality was observed in other 
physical examinations (chest and abdomen).Cherry-red 
spots were seen in 88% of patients (Fig.2). In lab data, 
three patients had increased levels of AST and ALT. 
The neuroimaging data showed that39% of patients had 
normal neuro-imaging; 22% of patients had bilateral 
thalamic involvement; 22% had brain atrophy, and 16% 
bilateral cherry-red spots in the macular region of the 
retina and seizures(3).The juvenile form manifests with 
dementia, cerebellar ataxia, mental retardation, and 
spinal muscular atrophy(4).The clinical manifestation of 
the adult form of Sandhoff disease varies widely from 
spinocerebellar degeneration to motor neuron disorders 
are often reported(5-8).
Tay-Sachs disease (TSD) is a neurodegenerative 
lysosomal disorder with an autosomal recessive 
inheritance caused by β-hexosaminidase α-subunit 
(HEXA) mutations (9).
The diagnosis of this disorder is based on 
hexosaminidases A, B, and AB level detection. 
Decreased levels of hexosaminidases A and B are seen 
in patients with Sandhoff but solitarily decreased levels 
of hexosaminidases A are seen in Tay Sachs disease.
In this study, we present 5 years of experience about 
Sandhoff and Tay Sachs disorder from the Pediatric 
Neurology Research Center of Mofid Children’s 
Hospital, Tehran, Iran. 
Materials & Methods
A total of 18 cases affected byGM2-gangliosidosis 
disease were assessed in our study from October 2009 
to February 2014 in the Neurology Department of Mofid 
Children’s Hospital, which is the referral center for 
neurometabolic diseases in Iran.
The diagnosis was performed based on clinical 
manifestations, neuro-imaging findings, and, finally, 
laboratory assessment of decreased total hexosaminidase 
enzyme activity for Tay Sachs and Sandhoff disease 
from a metabolic laboratory in Germany. The data from 
patients were collected was age, gender, past medical 
history, developmental status, general appearance, and 
clinical neuro-imaging findings.
Unfortunately, this disorder is incurable and treatment 
consists of anticonvulsants to manage seizures, proper 
nutrition, and rehabilitation. The children’s diet was 
carefully controlled. The data were analyzed by 
descriptive methods and no statistical testing was 
applied.
Institutional ethical approval for the conduct of this 
study was obtained from the Pediatric Neurology 
Research Center (Shahid Beheshti University of 
Medical Sciences). All parents signed a written consent 
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of patients showed demyelination delay. (Fig. 3 and 4).
Discussion
Sandhoff disease is the one type ofGM2-gangliosidosis 
may present with developmental regression within the 
first 6 months of life (10). Tay-Sachs diseaseis another 
type of GM2-gangliosidosis well-known inherited 
disease caused by an accumulation of gangliosidosis in 
the retina and brain (11).
Patients with GM2-Gangliosidosis (9 patients with 
Sandhoff disease and 9 patients with Tay Sachs disease) 
were referred to our tertiary center equally. There were 
no sexual differences. The main chief complaint from all 
patients for detection time was developmental delay or 
regression. 
Seizures were indicated in some cases. Four patients had 
a history of neonatal hospitalization (icter, infection) 
and four patients had recurrent hospitalization due to 
respiratory distress and Urinary Tract Infections (UTI). 
72% of patients had central hypotonicity or spasticity.
39% of patients had hyperacusis; 56% of patients had 
specific facial features;28% of patients had blonde 
hair and a sunken nose bridge; and 28% of patients 
had hypertelorism. 83% of patients were offspring of 
consanguineous marriages. Therefore, having relative 
parents is an important factor in GM2-gangliosidosis 
detection. 22% of our Sandhoff patients showed bilateral 
thalamic involvement as hyper-signal intensity of white 
matter in T2 weighted.
Yun YM et al reported MRIs that showed low signal 
intensity at the thalamus and high signal intensity at white 
matter of brain in T2-weighted(1). These manifestations 
in the infantile form of Sandhoff disease were caused by 
an accumulation of calcium due to intracellular storage 
of GM2-ganglioside(12-13).
Kokot W et al made proper diagnoses of Sandoff and 
Tay Sachs disease in their patients based on an early eye 
fundus examination and seeing cherry-red spots in the 
central area(14). 55% of our patients did not have fix-
follow on visual examination and cherry-red spots were 
seen in 88% of patients.
The treatment of GM2-gangliosidosis is based on patient 
complaints such as management of the epileptic seizures 
and an intervention program for the neurological 
retardation. Case mortality in the infantile form of this 
disorder with severe neurological deterioration occurs 
before the age of 4 (3).
Organomegaly was seen in only 2 patients and was not an 
important segregation criterionto distinguishing Sandhoff 
from Tay Sachs disease in our study. Likewise, Barness 
et al. also did not report organomegaly in patients with 
Sandhoff disease (15). However, Arisoy et al. reported a 
case of Tay Sachs in a twelve-month-old female patient 
with macrocephaly, hyperacusis, cherry-red spots, and 
without organomegaly (16). Ozkara et al. showed that 
in 11 out of 18 infantile patients with Sandhoff disease, 
there was no evidence of organomegaly, while the 
remaining seven had mild organomegaly(17). They also 
reported that 21% of marriages in their patients were 
consanguineous (17).
Therefore, the lack of organomegaly or macrocephaly in 
the clinical manifestation of our studied group could not 
preclude a GM2-gangliosidosis diagnosis.
Seven patients had macrocephaly, three patients had 
microcephaly, and eight patients had a normal head 
circumference. Therefore, macrocephaly, microcephaly, 
and normal head circumferences were not considered 
significant in our assessment.
Our patients with GM2-gangliosidosis came to our 
special center and an exact evaluation was done. A 
high frequency of consanguineous marriage between 
the patients’ parents must be considered remarkable. In 
these autosomal recessive disorders, because there is no 
curative therapy, genetic counselling is important and 
necessary to prevent the burden of GM2-gangliosidosis 
as a neuro-metabolic disorder.
In conclusions, the first and chief complaint in 100% of 
the patients were neurological disorders.
83% of patients were offspring of consanguineous 
marriages and cherry-red spots were seen in 88% of 
patients. Therefore, cherry-red spots, hyperacusis, 
refractory seizures, and relative parents in patients 
with developmental delay or regression are the most 
important factors in the diagnosis of suspected patients. 
These factors must be considered as assessment for 
GM2-gangliosidosis disease.
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Fig 1. A 9-month-old male patient with GM2-
gangliosidosis with a dysmorphic face, protruding 
forehead, and a depressed nasal bridge
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